Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders

Neuropsychopharmacology

Volumn 32, Issue 1, 2007, Pages 162-170

  Ehlis, Ann Christine ^a   Reif, Andreas ^a   Herrmann, Martin J ^a   Lesch, Klaus Peter ^a   Fallgatter, Andreas J ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Anterior cingulate cortex (ACC); COMT (catechol O methyltransferase); Executive functions; Prefrontal cortex; Response control; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BIPERIDEN; CARBAMAZEPINE; CATECHOL METHYLTRANSFERASE; CHLORPROMAZINE; LITHIUM; LORAZEPAM; METHIONINE; NEUROLEPTIC AGENT; PROTEIN P300; SEROTONIN UPTAKE INHIBITOR; VALINE; VALPROIC ACID;

ADULT; ALLELE; ARTICLE; BRAIN FUNCTION; COGNITION; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; FRONTAL LOBE; GENE DOSAGE; GENOTYPE; HANDEDNESS; HETEROZYGOTE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEUROPSYCHOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SCHIZOPHRENIA; SEX RATIO;

ADOLESCENT; ADULT; CATECHOL O-METHYLTRANSFERASE; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; GENOTYPE; HUMANS; MALE; METHIONINE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; POLYMORPHISM, SINGLE NUCLEOTIDE; PREFRONTAL CORTEX; PSYCHOMETRICS; SCHIZOPHRENIA; SCHIZOTYPAL PERSONALITY DISORDER; VALINE;

EID: 33845706859     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301151     Document Type: Article

References (52)

1. Abi-Dargham A, Moore H (2003). Prefrontal DA transmission at D1 receptors and the pathology of schizophrenia. Neuroscientist 9: 404-416.
2. Andreasen NC, Rezai K, Alliger R, Swayze VW, Flaum M, Kirchner P et al (1992). Hypofrontality in neuroleptic-naïve patients and in patients with chronic schizophrenia. Assessment with xenon 133 single-photon emission computed tomography and the Tower of London. Arch Gen Psychiatry 49: 943-958.
3. Badner JA, Gershon ES (2002). Meta-analysis of whole-genome linkage scans of bipolar disorder and schizophrenia. Mol Psychiatry 7: 405-411.
4. Bilder RM, Volavka J, Czobor P, Malhotra AK, Kennedy JL, Ni X et al (2002). Neurocognitive correlates of the COMT Val(158)Met polymorphism in chronic schizophrenia. Biol Psychiatry 52: 701-707.
5. Bokura H, Yamaguchi S, Kobayashi S (2001). Electrophysiological correlates for response inhibition in a Go/NoGo task. Clin Neurophysiol 112: 2224-2232.
6. Carter CS, MacDonald AW, Ross LL, Stenger VA (2001). Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am J Psychiatry 158: 1423-1428.
7. 2O PET study during single-trial Stroop task performance. Am J Psychiatry 154: 1670-1675.
8. Chen X, Wang X, O'Neill AF, Walsh D, Kendler KS (2004). Variants in the catechol-o-methyltranserase (COMT) gene are associated with schizophrenia in Irish high-density families. Mol Psychiatry 9: 962-967.
9. Craddock N, Owen MJ, O'Donovan MC (2006). The catechol-Omethyl transferase (COMT) gene as a candidate for psychiatric phenotypes: evidence and lessons. Mol Psychiatry 11: 446-458.
10. de Zubicaray GI, Zelaya FO, Andrew C, Williams SC, Bullmore ET (2000). Cerebral regions associated with verbal response initiation, suppression and strategy use. Neuropsychologia 38: 1292-1304.
11. 108/158Met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917-6922.
12. Fallgatter AJ (2001). Electrophysiology of the prefrontal cortex in healthy controls and schizophrenic patients: a review. J Neural Transm 108: 679-694.
13. Fallgatter AJ, Bartsch AJ, Herrmann MJ (2002). Electrophysiological measurements of anterior cingulate function. J Neural Transm 109: 977-988.
14. Fallgatter AJ, Bartsch AJ, Zielasek J, Herrmann MJ (2003). Brain electrical dysfunction of the anterior cingulate in schizophrenic patients. Psychiatry Res 124: 37-48.
15. Fallgatter AJ, Brandeis D, Strik WK (1997). A robust assessment of the NoGo-anteriorisation of P300 microstates in a cued Continuous Performance Test. Brain Topogr 9: 295-302.
16. Fallgatter AJ, Herrmann MJ, Roemmler J, Ehlis A-C, Wagener A, Heidrich A et al (2004). Allelic variation of serotonin transporter function modulates the brain electrical response for error processing. Neuropsychopharmacology 29: 1506-1511.
17. Fallgatter AJ, Mueller TJ (2001). Electrophysiological signs of reduced prefrontal response control in schizophrenic patients. Psychiatry Res Neuroimaging 107: 19-28.
18. Ford JM, Gray M, Whitfield SL, Turken AU, Glover G, Faustman WO et al (2004). Acquiring and inhibiting prepotent responses in schizophrenia: event-related brain potentials and functional magnetic resonance imaging. Arch Gen Psychiatry 61: 119-129.
19. Gaillard WD, Hertz-Pannier L, Mott SH, Barnett AS, LeBihan D, Theodore WH (2000). Functional anatomy of cognitive development: fMRI of verbal fluency in children and adults. Neurology 54: 180-185.
20. Gallinat J, Bajbouj M, Sander T, Schlattmann P, Xu K, Ferro EF et al (2003). Association of the G1947A COMT (Val(108/158)Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 54: 40-48.
21. Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS et al (2003). Executive subprocesses in working memory: relationship to catechol-O-methyltransferase Val158-Met genotype and schizophrenia. Arch Gen Psychiatry 60: 889-896.
22. Gruber SA, Rogowska J, Holcomb P, Soraci S, Yurgelun-Todd D (2002). Stroop performance in normal control subjects: an fMRI study. Neuroimage 16: 349-360.
23. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
24. Inada T, Nakamura A, Iijima Y (2003). Relationship between catechol-O-methyltransferase polymorphism and treatment-resistant schizophrenia. Am J Med Genet 120B: 35-39.
25. Ingvar DH, Franzen G (1974). Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia. Acta Psychiatr Scand 50: 425-462.
26. Jasper H (1958). Report of committee on methods of clinical exam in EEG. Electroencephalogr Clin Neurophysiol 10: 370-375.
27. Kay SR (1991). Positive and Negative Symptoms in Schizophrenia. Brunner/Mazel: New York.
28. Kiehl KA, Smith AM, Hare RD, Liddle PF (2000). An event-related potential investigation of response inhibition in schizophrenia and psychopathy. Biol Psychiatry 48: 210-221.
29. Kneavel M, Gogos J, Karayiorgou K, Luine V (2000). Interaction of COMT gene deletion and environment on cognition. Soc Neurosci Abstr 26: 571.20.
30. Kopp B, Rist F (1999). An event-related brain potential substrate of disturbed response monitoring in paranoid schizophrenic patients. J Abnorm Psychol 108: 337-346.
31. Laurens KR, Ngan ET, Bates AT, Kiehl KA, Liddle PF (2003). Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia. Brain 126: 610-622.
32. Lehmann D (1987). Principles of spatial analysis. In: Gevins A, Remond A (eds). Methods of Analysis of Brain Electrical and Magnetic Signals. Handbook of Electroencephalography and Clinical Neurophysiology. Elsevier: Amsterdam. pp 309-354.
33. Lehmann D, Skrandies W (1980). Reference-free identification of components of checkerboard-evoked multichannel potential fields. Electroencephalogr Clin Neurophysiol 48: 609-621.
34. Mathalon DH, Fedor M, Faustman WO, Gray M, Askari N, Ford JM (2002). Response-monitoring dysfunction in schizophrenia: an event-related brain potential study. J Abnorm Psychol 111: 22-41.
35. Matthews SC, Paulus MP, Simmons AN, Nelesen RA, Dimsdale JE (2004). Functional subdivisions within anterior cingulate cortex and their relationship to autonomic nervous system function. Neuroimage 22: 1151-1156.
36. Moll J, de Oliveira-Souza R, Moll FT, Bramati IE, Andreiuolo PA (2002). The cerebral correlates of set-shifting: an fMRI study of the trail making test. Arq Neuropsiquiatr 60: 900-905.
37. Nolan KA, Bilder RM, Lachman HM, Volavka J (2004). Catechol O-methyltransferase Val158Met polymorphism in schizophrenia: differential effects of Val and Met alleles on cognitive stability and flexibility. Am J Psychiatry 161: 359-361.
38. Overall JE, Gorham DR (1962). The brief psychiatric rating scale. Psychol Rev 10: 799-812.
39. Pascual-Marqui RD, Michel CM, Lehmann D (1994). Low resolution electromagnetic tomography, a new method for localizing electrical activity in the brain. Int J Psychophysiol 18: 49-65.
40. Reif A, Fallgatter AJ, Ehlis A-C, Lesch K-P (2004). Altered cingulate functioning in a case of chromosome 22q11 deletion syndrome. Psychiat Res Neuroimaging 132: 273-278.
41. Rubia K, Russell T, Bullmore ET, Soni W, Brammer MJ, Simmons A et al (2001). An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function. Schizophr Res 52: 47-55.
42. Sanders AR, Rusu I, Duan J, Vander Molen JE, Hou C, Schwab SG et al (2005). Haplotypic association spanning the 22q11.21 genes COMT and ARVCF with schizophrenia. Mol Psychiatry 10: 353-365.
43. Strandburg RJ, Marsh JT, Brown WS, Asarnow RF, Guthrie D, Harper R et al (1999). Continuous-processing related ERPs in adult schizophrenia: continuity with childhood onset schizophrenia. Biol Psychiatry 45: 1356-1369.
44. Strik WK, Fallgatter AJ, Brandeis D, Pascual-Marqui R (1998). Three dimensional tomography of event-related potentials during response inhibition: evidence for phasic frontal lobe activation. Electroencephalogr Clin Neurophysiol 108: 406-413.
45. Sullivan PF, Kendler KS, Neale MC (2003). Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60: 1187-1192.
46. Tamminga CA, Thaker GK, Buchanan R, Kirkpatrick B, Alphs LD, Chase TN et al (1992). Limbic system abnormalities identified in schizophrenia with fluorodeoxyglucose and neocortical alterations with the deficit syndrome. Arch Gen Psychiatry 49: 522-530.
47. Tsai S-J, Yu YW-Y, Chen T-J, Chen J-Y, Liou Y-J, Chen M-C et al (2003). Association study of a functional catechol-O-methyltransferase-gene polymorphism and cognitive function in healthy females. Neurosci Lett 338: 123-126.
48. 158Met and beyond. Biol Psychiatry, print copy in press (originally published online Feb. 14, 2006, at www.sciencedirect.com ).
49. Volz H, Gaser C, Hager F, Rzanny R, Ponisch J, Mentzel H et al (1999). Decreased frontal activation in schizophrenics during stimulation with the continuous performance test - a functional magnetic resonance imaging study. Eur Psychiatry 14: 17-24.
50. Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, Lipska BK et al (2001). Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50: 825-844.
51. Weisbrod M, Kiefer M, Marzinzik F, Spitzer M (2000). Executive control is disturbed in schizophrenia: evidence from event-related potentials in a Go/NoGo task. Biol Psychiatry 47: 51-60.
52. 108/158Met polymorphism of the COMT gene and schizophrenia. Am J Med Genet 120B: 47-50.